BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, Parodi A, Savarino V. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 2008;6:759-64. [PMID: 18456568 DOI: 10.1016/j.cgh.2008.02.054] [Cited by in Crossref: 134] [Cited by in F6Publishing: 143] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Sroka N, Rydzewska-Rosołowska A, Kakareko K, Rosołowski M, Głowińska I, Hryszko T. Show Me What You Have Inside-The Complex Interplay between SIBO and Multiple Medical Conditions-A Systematic Review. Nutrients 2022;15. [PMID: 36615748 DOI: 10.3390/nu15010090] [Reference Citation Analysis]
2 Delans K, Kelly K, Feldman SR. Treatment strategies, including antibiotics, to target the immune component of rosacea. Expert Rev Clin Immunol 2022;18:1239-51. [PMID: 36137266 DOI: 10.1080/1744666X.2022.2128334] [Reference Citation Analysis]
3 Li M, He SX, He YX, Hu XH, Zhou Z. Inflammatory bowel disease and rosacea: causal association analysis using bi-directional Mendelian randomization.. [DOI: 10.21203/rs.3.rs-2237564/v1] [Reference Citation Analysis]
4 Messina L, Bruno F, Licata P, Paola DD, Franco G, Marino Y, Peritore AF, Cuzzocrea S, Gugliandolo E, Crupi R. Snail Mucus Filtrate Reduces Inflammation in Canine Progenitor Epidermal Keratinocytes (CPEK). Animals 2022;12:1848. [DOI: 10.3390/ani12141848] [Reference Citation Analysis]
5 Zhang L, Cao H, Li L, Zhao W, Zhang F. Oral and external intervention on the crosstalk between microbial barrier and skin via foodborne functional component. Journal of Functional Foods 2022;92:105075. [DOI: 10.1016/j.jff.2022.105075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gürtler A, Schmitt L. Der Einfluss der Ernährung bei entzündlichen Gesichtsdermatosen. J Dtsch Dermatol Ges 2022;20:185-204. [PMID: 35146875 DOI: 10.1111/ddg.14683_g] [Reference Citation Analysis]
7 Gürtler A, Laurenz S. The impact of clinical nutrition on inflammatory skin diseases. J Dtsch Dermatol Ges 2022. [PMID: 35088524 DOI: 10.1111/ddg.14683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lizardo MV, Tavaria FK. Probiotics and skin health. Probiotics 2022. [DOI: 10.1016/b978-0-323-85170-1.00020-8] [Reference Citation Analysis]
9 de Oliveira GV. Rosacea and Microbiome. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00019-x] [Reference Citation Analysis]
10 Watanabe N, Matsunaga W, Gotoh A. Effects of Keishi-Bukuryo-gan-ka-Yokuinin on Rosacea Model Mice. BPB Reports 2022;5:147-153. [DOI: 10.1248/bpbreports.5.6_147] [Reference Citation Analysis]
11 Chugh P, Sood S, Dhar MS. Critical Inspection of the Gut–Brain–Skin Triangle and Its Modulation Through Probiotics. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-6760-2_2] [Reference Citation Analysis]
12 Morss-Walton P, McGee JS. Rosacea, not just skin deep: Understanding thesystemic disease burden. Clin Dermatol 2021;39:695-700. [PMID: 34809774 DOI: 10.1016/j.clindermatol.2020.08.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol 2021;39:829-39. [PMID: 34785010 DOI: 10.1016/j.clindermatol.2021.08.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
14 Karoglan A, Knödlseder N, Paetzold B. Dermatosen in neuem Licht. Dtsch Dermatolog 2021;69:914-921. [DOI: 10.1007/s15011-021-4772-2] [Reference Citation Analysis]
15 Alia E, Feng H. Rosacea pathogenesis, common triggers, and dietary role: The cause, the trigger, and the positive effects of different foods. Clin Dermatol 2021:S0738-081X(21)00216-9. [PMID: 34819228 DOI: 10.1016/j.clindermatol.2021.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Guidi EEA, Gramenzi A, Persico P, Di Prinzio R, Di Simone D, Cornegliani L. Effects of Feeding a Hypoallergenic Diet with a Nutraceutical on Fecal Dysbiosis Index and Clinical Manifestations of Canine Atopic Dermatitis. Animals (Basel) 2021;11:2985. [PMID: 34680004 DOI: 10.3390/ani11102985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J. Rosacea: New Concepts in Classification and Treatment. Am J Clin Dermatol 2021;22:457-65. [PMID: 33759078 DOI: 10.1007/s40257-021-00595-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
18 Gui X, Yang Z, Li MD. Effect of Cigarette Smoke on Gut Microbiota: State of Knowledge. Front Physiol 2021;12:673341. [PMID: 34220536 DOI: 10.3389/fphys.2021.673341] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
19 Vologzhanina LG, Borodina EN, Igumnova OA, Trapeznikova AA. Bacterial overgrowth syndrome with hyperammonemia as a cause of cognitive disorders. jour 2021. [DOI: 10.31146/1682-8658-ecg-186-2-79-87] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wang FY, Chi CC. Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut-Skin Axis of Rosacea. Adv Ther 2021;38:1415-24. [PMID: 33507499 DOI: 10.1007/s12325-021-01624-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
21 Wienholtz N, Ashina M, Thyssen JP, Egeberg A. Subtype-Specific Off-Label Treatment of Rosacea. Case Rep Dermatol 2021;13:121-8. [PMID: 33790755 DOI: 10.1159/000511984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions. Microorganisms 2021;9:353. [PMID: 33670115 DOI: 10.3390/microorganisms9020353] [Cited by in Crossref: 61] [Cited by in F6Publishing: 74] [Article Influence: 30.5] [Reference Citation Analysis]
23 Joura MI, Brunner A, Nemes-Nikodém É, Sárdy M, Ostorházi E. Interactions between immune system and the microbiome of skin, blood and gut in pathogenesis of rosacea. Acta Microbiol Immunol Hung 2021;68:1-6. [PMID: 33522984 DOI: 10.1556/030.2021.01366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Callewaert C, Knödlseder N, Karoglan A, Güell M, Paetzold B. Skin microbiome transplantation and manipulation: Current state of the art. Comput Struct Biotechnol J 2021;19:624-31. [PMID: 33510866 DOI: 10.1016/j.csbj.2021.01.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
25 Dosal J, Ceresnie M. Dietary Modifications for Acne and Rosacea. Integrative Dermatology 2021. [DOI: 10.1007/978-3-030-58954-7_7] [Reference Citation Analysis]
26 Chen Y, Lee W, Ho HJ, Tseng C, Wu C. An altered fecal microbial profiling in rosacea patients compared to matched controls. Journal of the Formosan Medical Association 2021;120:256-64. [DOI: 10.1016/j.jfma.2020.04.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
27 Matushevskaya E, Komissarenko I, Vladimirova E, Konev Y, Levchenko S. A modern view of the atopic dermatitis treatment from the position of dermatologist and gastroenterologist. Klin dermatol venerol 2021;20:104. [DOI: 10.17116/klinderma202120011104] [Reference Citation Analysis]
28 Jeffries M, Goldberg M, Treloar V. Functional Medicine Approaches. Integrative Dermatology 2021. [DOI: 10.1007/978-3-030-58954-7_9] [Reference Citation Analysis]
29 Daou H, Paradiso M, Hennessy K, Seminario-Vidal L. Rosacea and the Microbiome: A Systematic Review. Dermatol Ther (Heidelb) 2021;11:1-12. [PMID: 33170492 DOI: 10.1007/s13555-020-00460-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
30 Woo YR, Han YJ, Kim HS, Cho SH, Lee JD. Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis. Int J Mol Sci 2020;21:E8427. [PMID: 33182618 DOI: 10.3390/ijms21228427] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
31 Nickles MA, Hasan A, Shakhbazova A, Wright S, Chambers CJ, Sivamani RK. Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic Review. J Altern Complement Med 2021;27:108-19. [PMID: 33074705 DOI: 10.1089/acm.2020.0275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Greydanus DE, Azmeh R, Cabral MD, Dickson CA, Patel DR. Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life. Dis Mon 2021;67:101103. [PMID: 33041056 DOI: 10.1016/j.disamonth.2020.101103] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
33 Searle T, Ali FR, Carolides S, Al‐niaimi F. Rosacea and the gastrointestinal system. Australas J Dermatol 2020;61:307-11. [DOI: 10.1111/ajd.13401] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
34 Dai Y, Tai Y, Chen C, Chang Y, Chen T, Chen M. Use of proton pump inhibitors and risk of rosacea: A nationwide population‐based study. J Dermatol 2020;47:1126-30. [DOI: 10.1111/1346-8138.15478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Mann EA, Bae E, Kostyuchek D, Chung HJ, McGee JS. The Gut Microbiome: Human Health and Inflammatory Skin Diseases. Ann Dermatol 2020;32:265-72. [PMID: 33911753 DOI: 10.5021/ad.2020.32.4.265] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
36 Jabbehdari S, Memar OM, Caughlin B, Djalilian AR. Update on the pathogenesis and management of ocular rosacea: an interdisciplinary review. Eur J Ophthalmol 2021;31:22-33. [PMID: 32586107 DOI: 10.1177/1120672120937252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
37 Losurdo G, Salvatore D'Abramo F, Indellicati G, Lillo C, Ierardi E, Di Leo A. The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders. Int J Mol Sci 2020;21:E3531. [PMID: 32429454 DOI: 10.3390/ijms21103531] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
38 Rigoni R, Fontana E, Dobbs K, Marrella V, Taverniti V, Maina V, Facoetti A, D'Amico G, Al-Herz W, Cruz-Munoz ME, Schuetz C, Gennery AR, Garabedian EK, Giliani S, Draper D, Dbaibo G, Geha RS, Meyts I, Tousseyn T, Neven B, Moshous D, Fischer A, Schulz A, Finocchi A, Kuhns DB, Fink DL, Lionakis MS, Swamydas M, Guglielmetti S, Alejo J, Myles IA, Pittaluga S, Notarangelo LD, Villa A, Cassani B. Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome. J Allergy Clin Immunol 2020;146:1165-1179.e11. [PMID: 32311393 DOI: 10.1016/j.jaci.2020.04.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
39 Sorbellini E, De Padova MP, Rinaldi F. Coupled blue and red light-emitting diodes therapy efficacy in patients with rosacea: two case reports. J Med Case Rep 2020;14:22. [PMID: 31992343 DOI: 10.1186/s13256-019-2339-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Wilkin JK, Mcgee JS. Introduction to Clinical Rosacea. Rosacea 2020. [DOI: 10.1007/978-3-030-52097-7_1] [Reference Citation Analysis]
41 Wienholtz NKF, Thyssen JP, Egeberg A. Rosacea and Gastrointestinal Comorbidities. Rosacea 2020. [DOI: 10.1007/978-3-030-52097-7_8] [Reference Citation Analysis]
42 James M. Bacterial Overgrowth of the Small Intestine Breath Test. Textbook of Natural Medicine 2020. [DOI: 10.1016/b978-0-323-43044-9.00009-1] [Reference Citation Analysis]
43 Bustamante M, Oomah BD, Oliveira WP, Burgos-Díaz C, Rubilar M, Shene C. Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract. Folia Microbiol (Praha) 2020;65:245-64. [PMID: 31773556 DOI: 10.1007/s12223-019-00759-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
44 Polkowska‐pruszyńska B, Gerkowicz A, Krasowska D. The gut microbiome alterations in allergic and inflammatory skin diseases – an update. J Eur Acad Dermatol Venereol 2019;34:455-64. [DOI: 10.1111/jdv.15951] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
45 Wang FY, Chi CC. Association of rosacea with inflammatory bowel disease: A MOOSE-compliant meta-analysis. Medicine (Baltimore) 2019;98:e16448. [PMID: 31593075 DOI: 10.1097/MD.0000000000016448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
46 Knackstedt R, Knackstedt T, Gatherwright J. The role of topical probiotics in skin conditions: A systematic review of animal and human studies and implications for future therapies. Exp Dermatol 2019;29:15-21. [DOI: 10.1111/exd.14032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
47 Yu Y, Dunaway S, Champer J, Kim J, Alikhan A. Changing our microbiome: probiotics in dermatology. Br J Dermatol 2020;182:39-46. [PMID: 31049923 DOI: 10.1111/bjd.18088] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
48 Sikora M, Stec A, Chrabaszcz M, Waskiel-Burnat A, Zaremba M, Olszewska M, Rudnicka L. Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis. J Clin Med 2019;8:E1021. [PMID: 31336842 DOI: 10.3390/jcm8071021] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
49 Pellicciotta M, Rigoni R, Falcone EL, Holland SM, Villa A, Cassani B. The microbiome and immunodeficiencies: Lessons from rare diseases. J Autoimmun. 2019;98:132-148. [PMID: 30704941 DOI: 10.1016/j.jaut.2019.01.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
50 Clatici VG, Voicu C. Rosacea. Advances in Integrative Dermatology 2019. [DOI: 10.1002/9781119476009.ch5] [Reference Citation Analysis]
51 Di Nardo V, Daaboul F, Amey CE, Barygina V. Diet and Skin. Advances in Integrative Dermatology 2019. [DOI: 10.1002/9781119476009.ch19] [Reference Citation Analysis]
52 Singh AK, Gaur V, Singh SK. Biofilm-Mediated Skin Infections. Biofilms in Human Diseases: Treatment and Control 2019. [DOI: 10.1007/978-3-030-30757-8_14] [Reference Citation Analysis]
53 Ghosh G, Jesudian AB. Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis. J Clin Exp Hepatol 2019;9:257-67. [PMID: 31024208 DOI: 10.1016/j.jceh.2018.08.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
54 Buddenkotte J, Steinhoff M. Recent advances in understanding and managing rosacea. F1000Res 2018;7:F1000 Faculty Rev-1885. [PMID: 30631431 DOI: 10.12688/f1000research.16537.1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 13.0] [Reference Citation Analysis]
55 Hung CT, Chiang CP, Chung CH, Tsao CH, Chien WC, Wang WM. Risk of psychiatric disorders in rosacea: A nationwide, population-based, cohort study in Taiwan. J Dermatol 2019;46:110-6. [PMID: 30466187 DOI: 10.1111/1346-8138.14705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
56 Deidda F, Amoruso A, Nicola S, Graziano T, Pane M, Mogna L. New Approach in Acne Therapy: A Specific Bacteriocin Activity and a Targeted Anti IL-8 Property in Just 1 Probiotic Strain, the L. salivarius LS03. J Clin Gastroenterol 2018;52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S78-81. [PMID: 29782471 DOI: 10.1097/MCG.0000000000001053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
57 Maarouf M, Platto JF, Shi VY. The role of nutrition in inflammatory pilosebaceous disorders: Implication of the skin-gut axis. Australas J Dermatol 2019;60:e90-8. [PMID: 30175843 DOI: 10.1111/ajd.12909] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
58 Águila Bettancourt V, Norris Squirell F, Waissbluth Morales M. ¿Hay que tratar el intestino para mejorar la rosácea? Piel 2018;33:409-411. [DOI: 10.1016/j.piel.2017.09.011] [Reference Citation Analysis]
59 Porubsky CF, Glass AB, Comeau V, Buckley C, Goodman MB, Kober M. The Role of Probiotics in Acne and Rosacea. In: Enany S, editor. Probiotics - Current Knowledge and Future Prospects. InTech; 2018. [DOI: 10.5772/intechopen.79044] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, Thiboutot D. Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2018;78:167-70. [PMID: 29102687 DOI: 10.1016/j.jaad.2017.06.150] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
61 Vera N, Patel NU, Seminario-vidal L. Rosacea Comorbidities. Dermatologic Clinics 2018;36:115-22. [DOI: 10.1016/j.det.2017.11.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
62 Musthaq S, Mazuy A, Jakus J. The microbiome in dermatology. Clin Dermatol 2018;36:390-8. [PMID: 29908581 DOI: 10.1016/j.clindermatol.2018.03.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
63 Drago F, Ciccarese G, Herzum A, Rebora A, Parodi A. Rosacea and alcohol intake. Journal of the American Academy of Dermatology 2018;78:e25. [DOI: 10.1016/j.jaad.2017.08.063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
64 Ciccarese G, Parodi A, Rebora A, Drago F. The Possible Combined Action of Different Trigger Agents in Rosacea. Actas Dermo-Sifiliográficas (English Edition) 2018;109:91-92. [DOI: 10.1016/j.adengl.2017.07.015] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
65 Tungland B. The Gut-Brain-Skin Axis and Role of Intestinal Dysbiosis in Acne Vulgaris: Therapeutic Effects of Pro- and Prebiotic Use. Human Microbiota in Health and Disease 2018. [DOI: 10.1016/b978-0-12-814649-1.00013-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
66 Grobel H, Murphy SA. Acne Vulgaris and Acne Rosacea. Integrative Medicine 2018. [DOI: 10.1016/b978-0-323-35868-2.00077-3] [Reference Citation Analysis]
67 Rezaie A, Buresi M, Rao S. Response to Paterson et al. Am J Gastroenterol 2017;112:1889-92. [PMID: 29215623 DOI: 10.1038/ajg.2017.373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Vaughn AR, Notay M, Clark AK, Sivamani RK. Skin-gut axis: The relationship between intestinal bacteria and skin health. World J Dermatol 2017; 6(4): 52-58 [DOI: 10.5314/wjd.v6.i4.52] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
69 Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept 2017;7:31-7. [PMID: 29214107 DOI: 10.5826/dpc.0704a08] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
70 Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang ALS. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol 2018;78:156-66. [PMID: 29089181 DOI: 10.1016/j.jaad.2017.07.055] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
71 Ciccarese G, Parodi A, Rebora A, Drago F. The Possible Combined Action of Different Trigger Agents in Rosacea. Actas Dermosifiliogr (Engl Ed) 2018;109:91-2. [PMID: 29031487 DOI: 10.1016/j.ad.2017.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
72 Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment. Dermatoendocrinol 2017;9:e1361574. [PMID: 29484096 DOI: 10.1080/19381980.2017.1361574] [Cited by in Crossref: 69] [Cited by in F6Publishing: 50] [Article Influence: 11.5] [Reference Citation Analysis]
73 Ciccarese G, Parodi A, Rebora A, Drago F. The usefulness of investigating the possible underlying conditions in rosacea. J Eur Acad Dermatol Venereol 2018;32:e88-9. [DOI: 10.1111/jdv.14547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
74 Lazaridou E, Korfitis C, Kemanetzi C, Sotiriou E, Apalla Z, Vakirlis E, Fotiadou C, Lallas A, Ioannides D. Rosacea and Helicobacter pylori: links and risks. Clin Cosmet Investig Dermatol 2017;10:305-10. [PMID: 28848358 DOI: 10.2147/CCID.S121117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
75 Friedrich AD, Paz ML, Leoni J, González Maglio DH. Message in a Bottle: Dialog between Intestine and Skin Modulated by Probiotics. Int J Mol Sci 2017;18:E1067. [PMID: 28598354 DOI: 10.3390/ijms18061067] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
76 Jørgensen AR, Egeberg A, Gideonsson R, Weinstock LB, Thyssen EP, Thyssen JP. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2017;31:2010-5. [PMID: 28543746 DOI: 10.1111/jdv.14352] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
77 Drago F, De Col E, Agnoletti AF, Schiavetti I, Savarino V, Rebora A, Paolino S, Cozzani E, Parodi A. The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up. J Am Acad Dermatol 2016;75:e113-5. [PMID: 27543234 DOI: 10.1016/j.jaad.2016.01.059] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
78 Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther 2017;45:604-16. [PMID: 28078798 DOI: 10.1111/apt.13928] [Cited by in Crossref: 109] [Cited by in F6Publishing: 104] [Article Influence: 18.2] [Reference Citation Analysis]
79 Geerling G, Baudouin C, Aragona P, Rolando M, Boboridis KG, Benítez-Del-Castillo JM, Akova YA, Merayo-Lloves J, Labetoulle M, Steinhoff M, Messmer EM. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting. Ocul Surf 2017;15:179-92. [PMID: 28132878 DOI: 10.1016/j.jtos.2017.01.006] [Cited by in Crossref: 73] [Cited by in F6Publishing: 80] [Article Influence: 12.2] [Reference Citation Analysis]
80 Wu CY, Chang YT, Juan CK, Shieh JJ, Lin YP, Liu HN, Lin JT, Chen YJ. Risk of inflammatory bowel disease in patients with rosacea: Results from a nationwide cohort study in Taiwan. J Am Acad Dermatol 2017;76:911-7. [PMID: 28073582 DOI: 10.1016/j.jaad.2016.11.065] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
81 Egeberg A, Fowler JF Jr, Gislason GH, Thyssen JP. Nationwide Assessment of Cause-Specific Mortality in Patients with Rosacea: A Cohort Study in Denmark. Am J Clin Dermatol 2016;17:673-9. [PMID: 27480418 DOI: 10.1007/s40257-016-0217-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
82 Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell. 2017;8:90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell 2017;8:90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-6] [Cited by in Crossref: 136] [Cited by in F6Publishing: 144] [Article Influence: 19.4] [Reference Citation Analysis]
84 Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol 2017;176:100-6. [PMID: 27501017 DOI: 10.1111/bjd.14930] [Cited by in Crossref: 83] [Cited by in F6Publishing: 89] [Article Influence: 11.9] [Reference Citation Analysis]
85 Rezaie A, Pimentel M, Rao SS. How to Test and Treat Small Intestinal Bacterial Overgrowth: An Evidence-Based Approach. Curr Gastroenterol Rep. 2016;18:8. [PMID: 26780631 DOI: 10.1007/s11894-015-0482-9] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 12.3] [Reference Citation Analysis]
86 Savarino E, Furnari M, Ottonello A, Savarino V. It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients. Am J Gastroenterol 2016;111:1364. [PMID: 27580788 DOI: 10.1038/ajg.2016.290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 O'Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: A paradigm with therapeutic implications. Bioessays 2016;38:1167-76. [PMID: 27554239 DOI: 10.1002/bies.201600008] [Cited by in Crossref: 171] [Cited by in F6Publishing: 179] [Article Influence: 24.4] [Reference Citation Analysis]
88 Zákostelská Z, Málková J, Klimešová K, Rossmann P, Hornová M, Novosádová I, Stehlíková Z, Kostovčík M, Hudcovic T, Štepánková R, Jůzlová K, Hercogová J, Tlaskalová-Hogenová H, Kverka M. Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response. PLoS One 2016;11:e0159539. [PMID: 27434104 DOI: 10.1371/journal.pone.0159539] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 12.0] [Reference Citation Analysis]
89 McCusker M, Sidbury R. Nutrition and skin: Kids are not just little people. Clin Dermatol 2016;34:698-709. [PMID: 27968929 DOI: 10.1016/j.clindermatol.2016.07.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
90 Araviiskaia ER, Sokolovskiy EV. Microbiome: a new era in normal and pathological changes skin studies. Vestnik dermatologii i venerologii 2016;92:102-109. [DOI: 10.25208/0042-4609-2016-92-3-102-109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
91 Enko D, Halwachs-Baumann G, Stolba R, Mangge H, Kriegshäuser G. Refining small intestinal bacterial overgrowth diagnosis by means of carbohydrate specificity: a proof-of-concept study. Therap Adv Gastroenterol 2016;9:265-72. [PMID: 27134657 DOI: 10.1177/1756283X15621231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
92 Fortuna MC, Garelli V, Pranteda G, Romaniello F, Cardone M, Carlesimo M, Rossi A. A case of Scalp Rosacea treated with low dose doxycycline and probiotic therapy and literature review on therapeutic options. Dermatol Ther 2016;29:249-51. [PMID: 27087407 DOI: 10.1111/dth.12355] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
93 Craig JM. Atopic dermatitis and the intestinal microbiota in humans and dogs. Vet Med Sci 2016;2:95-105. [PMID: 29067183 DOI: 10.1002/vms3.24] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
94 Quigley EM. Bacterial Overgrowth. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch66] [Reference Citation Analysis]
95 Barona MI, Orozco B, Motta A, Meléndez E, Rojas RF, Pabón JG, Balcázar LF. Rosácea: actualización. Piel 2015;30:485-502. [DOI: 10.1016/j.piel.2015.02.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
96 Rainer BM, Fischer AH, Luz Felipe da Silva D, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity–dependent manner: Results of a case-control study. Journal of the American Academy of Dermatology 2015;73:604-8. [DOI: 10.1016/j.jaad.2015.07.009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 11.1] [Reference Citation Analysis]
97 Vaughn AR, Sivamani RK. Effects of Fermented Dairy Products on Skin: A Systematic Review. J Altern Complement Med 2015;21:380-5. [PMID: 26061422 DOI: 10.1089/acm.2014.0261] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
98 Vemuri RC, Gundamaraju R, Sekaran SD, Manikam R. Major pathophysiological correlations of rosacea: a complete clinical appraisal. Int J Med Sci 2015;12:387-96. [PMID: 26005373 DOI: 10.7150/ijms.10608] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
99 Amer S, Manzar HS. Small intestinal bacterial overgrowth in older people. Rev Clin Gerontol 2015;25:81-85. [DOI: 10.1017/s0959259815000118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. Interventions for rosacea. Cochrane Database Syst Rev 2015;:CD003262. [PMID: 25919144 DOI: 10.1002/14651858.CD003262.pub5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
101 Gravina A, Federico A, Ruocco E, Lo Schiavo A, Masarone M, Tuccillo C, Peccerillo F, Miranda A, Romano L, de Sio C, de Sio I, Persico M, Ruocco V, Riegler G, Loguercio C, Romano M. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United European Gastroenterol J. 2015;3:17-24. [PMID: 25653855 DOI: 10.1177/2050640614559262] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
102 Bowe W, Patel NB, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine. Benef Microbes 2014;5:185-99. [PMID: 23886975 DOI: 10.3920/BM2012.0060] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 7.2] [Reference Citation Analysis]
103 Picardo M, Ottaviani M. Skin microbiome and skin disease: the example of rosacea. J Clin Gastroenterol 2014;48 Suppl 1:S85-6. [PMID: 25291137 DOI: 10.1097/MCG.0000000000000241] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
104 Belge K, Schaller M. Aktuelle, alternative und künftige Wege zur erfolgreichen Behandlung. hautnah dermatologie 2014;30:24-35. [DOI: 10.1007/s15012-014-1885-2] [Reference Citation Analysis]
105 Fowler J, Tan J, Jackson JM, Meadows K, Jones T, Jarratt M, Leoni M; Brimonidine Phase III Study Group. Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema. J Eur Acad Dermatol Venereol 2015;29:474-81. [PMID: 25074756 DOI: 10.1111/jdv.12587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
106 Baquerizo Nole KL, Yim E, Keri JE. Probiotics and prebiotics in dermatology. J Am Acad Dermatol. 2014;71:814-821. [PMID: 24906613 DOI: 10.1016/j.jaad.2014.04.050] [Cited by in Crossref: 76] [Cited by in F6Publishing: 57] [Article Influence: 8.4] [Reference Citation Analysis]
107 Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, Justino E, Tomakin E, Mullin GE. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med 2014;3:16-24. [PMID: 24891990 DOI: 10.7453/gahmj.2014.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
108 Sewell JL, Somsouk M, Shah SC, Day LW. Commentary: Towards an effective and safe treatment of small intestine bacterial overgrowth - Authors' reply. Aliment Pharmacol Ther 2013;38:1411. [PMID: 24206377 DOI: 10.1111/apt.12533] [Reference Citation Analysis]
109 Scarpignato C, Gatta L. Commentary: Towards an effective and safe treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther 2013;38:1409-10. [PMID: 24206376 DOI: 10.1111/apt.12531] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
110 Grace E, Shaw C, Whelan K, Andreyev HJ. Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 2013;38:674-88. [PMID: 23957651 DOI: 10.1111/apt.12456] [Cited by in Crossref: 130] [Cited by in F6Publishing: 123] [Article Influence: 13.0] [Reference Citation Analysis]
111 Holmes AD. Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol. 2013;69:1025-1032. [PMID: 24011460 DOI: 10.1016/j.jaad.2013.08.006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 87] [Article Influence: 8.1] [Reference Citation Analysis]
112 Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013;4:223-231. [PMID: 23997926 DOI: 10.1177/2040622313496126] [Cited by in Crossref: 104] [Cited by in F6Publishing: 114] [Article Influence: 10.4] [Reference Citation Analysis]
113 Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin. J Am Acad Dermatol 2013;68:875-6. [PMID: 23602178 DOI: 10.1016/j.jaad.2012.11.038] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
114 de Lacy Costello BPJ, Ledochowski M, Ratcliffe NM. The importance of methane breath testing: a review. J Breath Res 2013;7:024001. [DOI: 10.1088/1752-7155/7/2/024001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 10.0] [Reference Citation Analysis]
115 Furnari M, Bonfanti D, Parodi A, Franzè J, Savarino E, Bruzzone L, Moscatelli A, Di Mario F, Dulbecco P, Savarino V. A comparison between lactose breath test and quick test on duodenal biopsies for diagnosing lactase deficiency in patients with self-reported lactose intolerance. J Clin Gastroenterol 2013;47:148-52. [PMID: 22495813 DOI: 10.1097/MCG.0b013e31824e9132] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
116 Thomson AB, Chopra A, Clandinin MT, Freeman H. Recent advances in small bowel diseases: Part I. World J Gastroenterol. 2012;18:3336-3352. [PMID: 22807604 DOI: 10.3748/wjg.v18.i26.3336.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Thomson AB, Chopra A, Clandinin MT, Freeman H. Recent advances in small bowel diseases: Part I. World J Gastroenterol 2012; 18(26): 3336-3352 [PMID: 22807604 DOI: 10.3748/wjg.v18.i26.3336] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
118 Weinstock LB, Zeiss S. Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study: Antibiotic therapy for RLS. Sleep and Biological Rhythms 2012;10:145-53. [DOI: 10.1111/j.1479-8425.2012.00537.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
119 Weinstock LB, Walters AS, Paueksakon P. Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms. Sleep Med Rev 2012;16:341-54. [PMID: 22258033 DOI: 10.1016/j.smrv.2011.09.003] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 8.6] [Reference Citation Analysis]
120 Zager SH. Acne Vulgaris and Acne Rosacea. Integrative Medicine 2012. [DOI: 10.1016/b978-1-4377-1793-8.00057-1] [Reference Citation Analysis]
121 Cribier B. Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Annales de Dermatologie et de Vénéréologie 2011;138:S184-91. [DOI: 10.1016/s0151-9638(11)70088-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
122 Parodi A, Drago F, Paolino S, Cozzani E, Gallo R. Treatment of rosacea. Annales de Dermatologie et de Vénéréologie 2011;138:S211-4. [DOI: 10.1016/s0151-9638(11)70092-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
123 Parodi A, Drago F, Paolino S, Cozzani E, Gallo R. Prise en charge thérapeutique de la rosacée. Annales de Dermatologie et de Vénéréologie 2011;138:S158-S162. [DOI: 10.1016/s0151-9638(11)70082-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
124 Cribier B. Physiopathologie de la rosacée. Rougeurs, couperose et rosacée. Annales de Dermatologie et de Vénéréologie 2011;138:S129-37. [DOI: 10.1016/s0151-9638(11)70078-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
125 van Zuuren EJ, Kramer S, Carter B, Graber MA, Fedorowicz Z. Interventions for rosacea. Cochrane Database Syst Rev 2011;:CD003262. [PMID: 21412882 DOI: 10.1002/14651858.CD003262.pub4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
126 Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am. 2010;24:943-959, viii-ix. [PMID: 20937459 DOI: 10.1016/j.idc.2010.07.007] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 6.3] [Reference Citation Analysis]
127 Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? Gut Pathog. 2011;3:1. [PMID: 21281494 DOI: 10.1186/1757-4749-3-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 130] [Article Influence: 10.1] [Reference Citation Analysis]
128 Attar A, Bouhnik Y. Colonisation bactérienne chronique de l'intestin grêle. EMC - Gastro-entérologie 2011;6:1-8. [DOI: 10.1016/s1155-1968(11)53816-7] [Reference Citation Analysis]
129 Lazaridou E, Giannopoulou C, Fotiadou C, Vakirlis E, Trigoni A, Ioannides D. The potential role of microorganisms in the development of rosacea. J Dtsch Dermatol Ges. 2011;9:21-25. [PMID: 21059171 DOI: 10.1111/j.1610-0387.2010.07513.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
130 Gallo R, Drago F, Paolino S, Parodi A. Rosacea treatments: What's new and what's on the horizon? Am J Clin Dermatol 2010;11:299-303. [PMID: 20642292 DOI: 10.2165/11537020-000000000-00000] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
131 Furnari M, Parodi A, Gemignani L, Giannini EG, Marenco S, Savarino E, Assandri L, Fazio V, Bonfanti D, Inferrera S, Savarino V. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2010;32:1000-6. [PMID: 20937045 DOI: 10.1111/j.1365-2036.2010.04436.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
132 Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16(24): 2978-2990 [PMID: 20572300 DOI: 10.3748/wjg.v16.i24.2978] [Cited by in CrossRef: 373] [Cited by in F6Publishing: 416] [Article Influence: 28.7] [Reference Citation Analysis]
133 Cribier B. Rosacée. EMC - Dermatologie 2010;5:1-12. [DOI: 10.1016/s0246-0319(10)44806-2] [Reference Citation Analysis]
134 Cribier B. Rosácea. EMC - Dermatología 2010;44:1-13. [DOI: 10.1016/s1761-2896(10)70331-9] [Reference Citation Analysis]
135 O’mahony S, Shanahan F. Enteric Microbiota and Small Intestinal Bacterial Overgrowth. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00102-5] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
136 Weinstock LB. Antibiotic therapy may improve idiopathic restless legs syndrome: prospective, open-label pilot study of rifaximin, a nonsystemic antibiotic. Sleep Med. 2010;11:427. [PMID: 20042368 DOI: 10.1016/j.sleep.2009.06.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
137 Whitehead J. Intestinal alkaline phosphatase: The molecular link between rosacea and gastrointestinal disease? Medical Hypotheses 2009;73:1019-22. [DOI: 10.1016/j.mehy.2009.02.049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
138 Parodi A, Dulbecco P, Savarino E, Giannini EG, Bodini G, Corbo M, Isola L, De Conca S, Marabotto E, Savarino V. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol 2009;43:962-6. [PMID: 19525858 DOI: 10.1097/MCG.0b013e3181a099a5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
139 Tsai F, Coyle WJ. The microbiome and obesity: is obesity linked to our gut flora? Curr Gastroenterol Rep. 2009;11:307-313. [PMID: 19615307 DOI: 10.1007/s11894-009-0045-z] [Cited by in Crossref: 117] [Cited by in F6Publishing: 121] [Article Influence: 8.4] [Reference Citation Analysis]
140 Ojetti V, Lauritano EC, Barbaro F, Migneco A, Ainora ME, Fontana L, Gabrielli M, Gasbarrini A. Rifaximin pharmacology and clinical implications. Expert Opin Drug Metab Toxicol. 2009;5:675-682. [PMID: 19442033 DOI: 10.1517/17425250902973695] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
141 Parodi A, Lauritano E, Nardone G, Fontana L, Savarino V, Gasbarrini A. Small intestinal bacterial overgrowth. Digestive and Liver Disease Supplements 2009;3:44-9. [DOI: 10.1016/s1594-5804(09)60019-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
142 Eradication of small intestinal bacterial overgrowth improves cutaneous lesions in rosacea. Nat Rev Gastroenterol Hepatol 2008;5:534-535. [DOI: 10.1038/ncpgasthep1240] [Reference Citation Analysis]